FDA grants Fast Track designation to pelareorep in anal cancer
Oncolytics Biotech received Fast Track designation for pelareorep in second-line and later anal cancer, which the company believes validates an estimated $1 billion market. This is…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Oncolytics Biotech received Fast Track designation for pelareorep in second-line and later anal cancer, which the company believes validates an estimated $1 billion market. This is…
EPR Properties executed a Fifth Amended, Restated and Consolidated Credit Agreement dated July 17, 2026, modifying its credit facility with an expanded group of financial instituti…
Niki BioSolutions filed an exhibit (3.1) relating to its Articles of Incorporation with the SEC, indicating a corporate update or standard governance filing relevant to its structu…
Armata submitted a Phase 3 protocol and FDA responses to advance its staphylococcus aureus therapy toward a pivotal 2026 trial, supported by DoD funding.
Rockwell Medical announced it has regained compliance with Nasdaq's minimum bid price requirement by maintaining $1.00 closing bid prices from July 1 to July 15, 2026. As a result,…
Duke Energy Carolinas reduced its requested retail revenue increase to roughly $622 million over two years. This adjustment reflects a negotiated concession with regulators and may…
Willis Lease Finance Corporation amended its certificate of incorporation to authorize 75 million shares of stock, comprising 15 million preferred and 60 million common shares. Thi…
Leonardo DRS filed an updated Code of Ethics and Business Conduct outlining company values and compliance procedures. This standard governance filing reinforces the company's commi…
The Grayscale Solana Staking ETF filed a third amended and restated declaration of trust agreement. This document outlines the fund's fiduciary powers, management structure, and So…
The Sponsor and Trustee amended the Second Amended and Restated Declaration of Trust to update the Fund's purposes and powers, including engaging in staking activities. This regula…
Altus Group U.S. Inc. provided a consent for its valuation role regarding the REIT's June 30, 2026 NAV. This submission is required for compliance with securities regulations and r…
The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, to reduce LDL cholesterol in adults with high cholesterol when used with diet and exercise. This represents…
Hines Global Income Trust formally consented to the inclusion of its valuation advisor roles in future SEC filings. This administrative step is necessary to support the company's u…
Federal agencies are issuing joint guidance to reinforce protocols for the secure handling of sensitive information gathered during bank examinations.
Bally's Chicago, Inc. filed a Third Amended and Restated Certificate of Incorporation detailing its authorized share classes and business purpose. This corporate filing establishes…
The Pennsylvania Public Utility Commission approved a rate adjustment for Pennsylvania American Water authorizing an approximately $74.9 million annual revenue increase. This decis…
Cycurion received notice of potential delisting after failing to maintain a $1.00 minimum bid price for 31 consecutive days, though trading will continue while the company appeals.
Auditors issued an unqualified opinion, confirming that Parkland's 2024 consolidated financial statements fairly present the company's financial position. This regulatory release c…
QumulusAI, Inc. filed a second amended and restated articles of incorporation to update its authorized capital structure. This regulatory filing establishes the company's maximum s…
The Federal Reserve Board announced an enforcement action against the former chief lending officer of Heritage State Bank. The specific details of the violation were not disclosed.